What type of study is this?

This is a Literature Review study.

Unraveling the Epigenetic Landscape of Mature B Cell Neoplasia: Mechanisms, Biomarkers, and Therapeutic Opportunities

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis determined the role of epigenetic mutations in B cell cancers, indicating potential therapeutic targets.

Mutations in epigenetic regulators drive changes in B cell neoplasms and impact clinical outcomes.
In diffuse large B cell lymphoma, hypermethylation and CREBBP mutations are linked to immune evasion and treatment resistance.
Targeted therapies like the EZH2 inhibitor tazemetostat show efficacy in certain B cell malignancies.
Understanding epigenetic alterations could improve strategies for managing mature B cell neoplasms.

Maher et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark